Previous 10 | Next 10 |
China SXT Pharmaceuticals (NASDAQ:SXTC) entered into a securities purchase agreement to issue a convertible promissory note in the original principal amount of $2.8M to Streeterville Capital, a Utah limited liability company. The 12-month note shall bear annual interest of 6%. ...
TAIZHOU, China, March 14, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"),...
NEW YORK, NY / ACCESSWIRE / January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC). About China SXT Pharmaceuticals, Inc. Fou...
TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), includ...
TAIZHOU, China, Jan. 18, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), includ...
TAIZHOU, China, Jan. 14, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), includ...
China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin PR Newswire TAIZHOU, China, Jan. 14, 2022 /PRNewswire/ -- China SXT Pha...
Top Penny Stocks to Watch Premarket During premarket, penny stocks and blue chips looked to start the day lower with U.S. stock futures pointing down. In early morning trading, shares of JPMorgan Chase & Co ( NYSE: JPM ) had dropped by around 3% despite the bank beating estimate...
China SXT Pharmaceuticals (NASDAQ:SXTC) received a notification letter from the Nasdaq Listing Qualifications notifying that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and it no longer meets the ...
China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection PR Newswire TAIZHOU, China , Oct. 18, 2021 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the...
News, Short Squeeze, Breakout and More Instantly...
China SXT Pharmaceuticals Inc. Company Name:
SXTC Stock Symbol:
NASDAQ Market:
China SXT Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 50.1% to $0.1783 on volume of 599,794,977 shares WiSA Technologies Inc. (WISA) rose 248.6% to $6.1 on volume of 197,912,579 shares PROSHARES TRUST (SQQQ) rose 0.0% to $11.44 on volume of 182,001,060 shar...
FMC Corporation (FMC) is expected to report $0.45 for Q3 2023 NCS Multistage Holdings Inc. (NCSM) is expected to report $2.59 for Q3 2023 Third Century Bancorp (TDCB) is expected to report for Q3 2023 ZoomInfo Technologies Inc. (ZI) is expected to report $0.15 for Q3 2023 Matson I...
China SXT Pharmaceuticals Inc. (SXTC) is expected to report for quarter end 2023-06-30